Citywire case study: the managers to back in the booming world of biotech citywireselector.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citywireselector.com Daily Mail and Mail on Sunday newspapers.
Invesco Ltd. (NYSE: IVZ), a leading global asset manager, announced today the launch of two new exchange-traded funds (ETFs) that capture timely technology themes – biotechnology and semiconductors. The new ETFs will track the Nasdaq Biotechnology Index and the PHLX Semiconductor Sector Index. These indexes, which are maintained by Nasdaq, Inc. (Nasdaq), are the longest-standing benchmarks for each of the themes that have increased in relevance through the current events of the past year.
<p><span class="xn-org">Invesco Ltd.</span><span> (NYSE: IVZ), a leading global asset manager, announced today the launch of two new exchange-traded funds (ETFs) that capture timely technology themes – biotechnology and semiconductors. The new ETFs will track the Nasdaq Biotechnology Index and the PHLX Semiconductor Sector Index. These indexes, which are maintained by </span><span class="xn-org">Nasdaq, Inc.</span><span> (Nasdaq), are the longest-standing benchmarks for each of the themes that have increased in relevance through the current events of the past year.</span></p>
U.S. stocks mixed, yields rise on Fed minutes
U.S. Fed will leave the punch bowl out for investors to get tipsy : Invesco strategist
Stan Wong s Top Picks: May 19, 2021
Cathie Wood buys more Tesla amid Musk Bitcoin spat, Burry shorts
Squarespace shares given US$50 reference price for NYSE debut
Bitcoin whipsaws investors with same-day plunge, rally of 30%
Burry of Big Short fame places big bet against Musk, Tesla
Fund managers say long Bitcoin is the most crowded trade in the world
Ares gets US$500M from Ontario Pension for credit deals
Bitcoin chartists see rout worsening with $40,000 in focus
Nasdaq, S&P 500 slip as COVID-19 vaccine makers fall
By Shreyashi Sanyal and Sruthi Shankar
Reuters
(Reuters) - The Nasdaq and the S&P 500 slipped on Thursday as vaccine makers fell after President Joe Biden announced plans to back intellectual property waivers on COVID-19 shots, but losses were capped by an upbeat jobless claims report.
Shares in Pfizer Inc, Moderna Inc, Johnson & Johnson and Novavax Inc, all involved in the making of COVID-19 vaccines, fell between 0.2% and 9.3%.
The declines were triggered after Biden said he had backed a World Trade Organization waiver for vaccine intellectual property to enhance the fight against the pandemic.